会員登録
ログイン
【4890】坪田ラボ
近視、ドライアイ、老眼等の治療に係る医薬品、医療機器等の研究開発
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.03 | 2024/03/07 | 修正予 | 688 | ↑ | +189.1% | -33.8% | -680 | ↑ | +39.8% | -2293.5% | -675 | ↑ | +40.0% | -2350.0% | -680 | ↑ | +39.8% | -3500.0% |
| 2024.03 | 2024/02/13 | Q3予 | 238 | → | 0.0% | -77.1% | -1,130 | → | 0.0% | -3745.2% | -1,125 | → | 0.0% | -3850.0% | -1,130 | → | 0.0% | -5750.0% |
| 2024.03 | 2024/02/08 | 修正予 | 238 | ↓ | -77.1% | -77.1% | -1,130 | ↓ | -3745.2% | -3745.2% | -1,125 | ↓ | -3850.0% | -3850.0% | -1,130 | ↓ | -5750.0% | -5750.0% |
| 2024.03 | 2023/11/10 | Q2予 | 1,039 | → | 0.0% | 0.0% | 31 | → | 0.0% | 0.0% | 30 | → | 0.0% | 0.0% | 20 | → | 0.0% | 0.0% |
| 2024.03 | 2023/08/10 | Q1予 | 1,039 | → | 0.0% | 0.0% | 31 | → | 0.0% | 0.0% | 30 | → | 0.0% | 0.0% | 20 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/12 | 当初予 | 1,039 | - | - | - | 31 | - | - | - | 30 | - | - | - | 20 | - | - | - |
| 2023.03 | 2023/05/12 | 実 | 954 | ↓ | -0.1% | -25.4% | 167 | ↓ | -10.7% | -36.3% | 144 | ↓ | -12.2% | -45.0% | 90 | ↓ | -16.7% | -50.3% |
| 2023.03 | 2023/03/29 | 修正予 | 955 | ↓ | -25.3% | -25.3% | 187 | ↓ | -28.6% | -28.6% | 164 | ↓ | -37.4% | -37.4% | 108 | ↓ | -40.3% | -40.3% |
| 2023.03 | 2023/02/10 | Q3予 | 1,278 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 181 | → | 0.0% | 0.0% |
| 2023.03 | 2022/11/10 | Q2予 | 1,278 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 262 | → | 0.0% | 0.0% | 181 | → | 0.0% | 0.0% |
| 2023.03 | 2022/08/12 | 当初予 | 1,278 | - | - | - | 262 | - | - | - | 262 | - | - | - | 181 | - | - | - |
